EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 14 listopada 2024. Database contains 4821 unique substances/entries.
Filter the list
|
210-852-7
|
624-54-4
|
Flam. Liq. 3 |
|||
|
210-843-8
|
624-41-9
|
Flam. Liq. 3 |
|||
|
210-834-9
|
624-18-0
|
Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1 |
|||
|
210-769-6
|
623-08-5
|
Acute Tox. 3; STOT RE 2 |
|||
|
DI(2-ETHYLHEXYL)DITHIODIGLYKOLAT; DP 327
|
404-510-8
|
62268-47-7
|
Acute Tox. 4; Skin Sens. 1 |
||
|
263-467-1
|
62229-08-7
|
yes |
|||
|
210-698-0
|
621-64-7
|
Carc. 1B; Acute Tox. 4 |
|||
|
DPX-D-7556
|
403-580-7
|
62096-63-3
|
Acute Tox. 4 |
||
|
700-242-3
|
62037-80-3
|
yes |
|||
|
-
|
6202-15-9
|
Expl. 1.1; Acute Tox. 4 |
|||
|
200-549-8
|
62-75-9
|
Carc. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1 |
|||
|
200-548-2
|
62-74-8
|
Acute Tox. 2; Acute Tox. 1 |
|||
|
200-547-7
|
62-73-7
|
Acute Tox. 2; Acute Tox. 3; Skin Sens. 1 |
|||
|
200-543-5
|
62-56-6
|
Carc. 2; Repr. 2; Acute Tox. 4 |
|||
|
200-541-4
|
62-55-5
|
Carc. 1B; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
|||
|
200-539-3
|
62-53-3
|
Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Skin Sens. 1 |
|||
|
200-532-5
|
62-38-4
|
Acute Tox. 3; STOT RE 1; Skin Corr. 1B |
|||
|
428-020-9
|
6195-20-6
|
Skin Sens. 1 |
|||
|
426-620-5
|
619297-89-1
|
Eye Dam. 1 |
|||
|
210-621-0
|
619-99-8
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
210-581-4
|
619-15-8
|
Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3; STOT RE 2 |
|||
|
441-070-6
|
61826-76-4
|
Acute Tox. 3; Eye Dam. 1; Skin Sens. 1 |
|||
|
X-17-17
|
417-410-4
|
61807-67-8
|
Acute Tox. 4; Skin Corr. 1A; Skin Sens. 1 |
||
|
210-566-2
|
618-85-9
|
Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3; STOT RE 2 |
|||
|
202-706-6
|
618-36-0;98-84-0
|
Acute Tox. 4; Skin Corr. 1B |
|||